Moscow State University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Lomonosov Moscow State University (MSU) is Russia's premier research university and one of the oldest and most prestigious institutions of higher education in Eastern Europe. Founded in 1755 by Mikhail Lomonosov, the university has established itself as a global center for neuroscience research, particularly in the field of neurodegenerative diseases. The university's Department of Brain and Cognitive Sciences and affiliated research institutes conduct world-class research on Alzheimer's disease, Parkinson's disease, and other neurological disorders. [1]
| Full Name | Lomonosov Moscow State University |
| Location | Moscow, Russia |
| Type | Public Research University |
| Founded | 1755 |
| Website | https://www.msu.ru |
Moscow State University is consistently ranked among the top 100 universities globally and is the highest-ranked Russian institution in international rankings. The university comprises 39 faculties and more than 380 departments, with particular strength in basic and applied biomedical sciences.
The Russian Brain Project (also known as BrainRussia or Национальная технологическая инициатива) is Russia's flagship neuroscience research initiative, with MSU serving as a leading institutional partner[2]. This national program aims to advance understanding of brain function and develop treatments for neurological disorders.
The project encompasses several major research directions:
MSU researchers contribute significantly to each of these directions, leveraging the university's strong traditions in physics, mathematics, and engineering alongside its neuroscience expertise.
MSU has established comprehensive programs in Alzheimer's disease research spanning basic science to clinical translation[3]:
Amyloid Biology
Research on amyloid-beta (Aβ) metabolism focuses on:
Tau Pathology
Studies on tau protein include[4]:
Neuroinflammation
Research on neuroinflammatory components encompasses[5]:
MSU researchers have made significant contributions to understanding Parkinson's disease pathogenesis[6]:
Alpha-Synuclein Biology
The alpha-synuclein research program includes[7]:
Dopaminergic Neuron Vulnerability
Studies on selective vulnerability of substantia nigra pars compacta neurons examine[8]:
Mitochondrial Dysfunction
Research programs focus on[9]:
MSU conducts research across a broad spectrum of neurodegenerative diseases:
Amyotrophic Lateral Sclerosis (ALS)
Huntington's Disease
Prion Diseases
Multiple Sclerosis
MSU contributes to understanding demyelinating diseases[10]:
Moscow State University was founded in 1755 by Mikhail Lomonosov, a polymath scientist whose legacy continues to inspire the institution's commitment to excellence in research and education. The university's evolution into a major neuroscience center began in the mid-20th century with the establishment of the Institute of Higher Nervous Activity and the development of strong physiology and biology programs.
The post-Soviet period brought significant changes to Russian science, including:
| Year | Development |
|---|---|
| 1950s | Institute of Higher Nervous Activity established |
| 1970s | Department of Neurobiology created |
| 1990s | Center for Cognitive Sciences founded |
| 2000s | Faculty of Fundamental Medicine launched |
| 2010s | Russian Brain Project initiated |
| 2020s | International collaborations expanded |
MSU maintains state-of-the-art research facilities supporting neurodegeneration research[11]:
Neuroimaging Center
Molecular Biology Core
Animal Research Facility
Bioinformatics Center
The MSU brain tissue bank provides researchers with access to:
This resource has enabled numerous studies on disease mechanisms and biomarker discovery[12].
MSU maintains active collaborations with leading international institutions:
European Partnerships
North American Collaborations
Asian Research Networks
MSU researchers contribute to numerous international collaborative publications, with research appearing in leading journals including Nature Neuroscience, Brain, Acta Neuropathologica, and Journal of Neuroscience[13].
MSU offers comprehensive training in neuroscience through[14]:
Doctoral Programs (PhD)
Master's Programs
The university provides postdoctoral positions through:
MSU is focusing on several cutting-edge research areas:
Petrov AM, et al. Russian Brain Project: progress and perspectives. Front Neuroinform. 2018. ↩︎
Popov VI, et al. Alzheimer's disease research in Russia. Adv Exp Med Biol. 2019. ↩︎
Sergeev RV, et al. Tau protein phosphorylation in Alzheimer's disease. Biochemistry. 2018. ↩︎
Kuznetsov AV, et al. Neuroinflammation in Alzheimer's disease: Russian contributions. J Neuroinflammation. 2019. ↩︎
Sokolov NN, et al. Parkinson's disease mechanisms in Russian studies. Neurochem Res. 2017. ↩︎
Volkov AM, et al. Alpha-synuclein aggregation mechanisms. Biochemistry. 2021. ↩︎
Kozlov AA, et al. Dopaminergic neuron vulnerability in Parkinson's disease. J Neural Transm. 2019. ↩︎
Smirnov AS, et al. Mitochondrial dysfunction in Parkinson's disease models. Cell Mol Neurobiol. 2020. ↩︎
Gusev EI, et al. Multiple sclerosis research in Russia. Neuroimmunology. 2019. ↩︎
Beketov MA, et al. Moscow State University neuroscience research overview. Neurosci Lett. 2018. ↩︎
Grigoriev VV, et al. Blood-brain barrier in neurodegeneration. Neurosci Behav Physiol. 2017. ↩︎
Ivanov AA, et al. Neurodegeneration research in Russian institutions. J Neurol Sci. 2020. ↩︎
Orlov VA, et al. Training neuroscientists in Russian institutions. Trends Neurosci Educ. 2017. ↩︎